[1]
“Impact of Clinical Pharmacist-Vancomycin Monitoring on Patient Safety Outcome”, acbr, vol. 4, no. 5, pp. 441–452, Oct. 2020, Accessed: Sep. 17, 2026. Available: https://fortunejournals.org/ojs/index.php/acbr/article/view/14782